StockData
20/20 Biolabs, Inc. logo

20/20 Biolabs, Inc. (AIDX) stock

AIDXNasdaqServices-Testing LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3069% below fair value
$0.18−0.02 (-9.45%)

Close on Nov 16, 2026Market cap $2.36MP/E –Yield –

20/20 Biolabs EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2025 it was -$0.76.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$0.76–
FY2024Dec 31, 2024-$1.16–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$0.26–
Q1 FY2026Mar 31, 2026-$0.28–
Q2 FY2025Jun 30, 2025-$0.17–
Q1 FY2025Mar 31, 2025-$0.16–

More 20/20 Biolabs figures

See a number that looks wrong?